Mizuho Securities Reiterates Buy Rating on CVS Health (CVS) Following 3Q EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CVS Health Reports Third Quarter Results
November 6, 2019 6:30 AM ESTWOONSOCKET, R.I., Nov. 6, 2019 /PRNewswire/ --
Third Quarter Year-over-Year Highlights:
Total revenues increased 36.5% to $64.8 billion GAAP operating income increased 13.8% to $2.9 billion Adjusted operating income (1) increased 48.9% to $3.9 billion GAAP diluted earnings per share from continuing operations of $1.17 Adjusted EPS (2) of $1.84Year-to-date Highlights:
Generated cash flow from operations of $10.2 billion2019 Full Year Guidance:
Revised GAAP operating income guidance range to $11.77 billion to $11.95 billion from $11.82 billion to $12.02 billion Raised and narrowed adjusted operating... More